Inhibition of androgen biosynthesis, silence of AR expression or interruption of the androgen/AR-associated signaling pathways would be able to offer promising therapeutic strategies to treat PCa and its advanced disease. The gene discussed is AR; the disease is posterior cortical atrophy.